(“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that its research ...

Favorable safety and tolerability, with promising early activity of novel mRNA-based therapy observed from interim data– ...

BRANFORD, CT, USA I May 28, 2025 I Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies ...

WHIPPANY, NJ, USA I May 28, 2025 I Bayer announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application ...

INDICATIONS AND USAGE TRYPTYR (acoltremon ophthalmic solution) 0.003% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).

SHENZHEN, China I May 28, 2025 I On May 26th, Kexing Biopharm (688136.SH) announced that the National Medical Products Administration (NMPA) has approved ...

SAN DIEGO, CA, USA I May 27, 2025 I Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development ...

MUNICH, Germany and WILMINGTON, DE, USA I May 28, 2025 I DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug ...

Trial is evaluating the safety, tolerability, and efficacy of LTI-03 in idiopathic pulmonary fibrosis (IPF) with topline interim data expected in the first ...

JENA, Germany I May 28, 2025 I InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the ...

CRANBURY, NJ, USA I May 27, 2025 I Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing an integrated ...

SOUTH SAN FRANCISCO, CA, USA I May 27, 2025 I Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for ...